Posts tagged All News
July IIP at 4.2% versus 4.4% in June (11-09-2015)
Manufacturing grew 4.7% while consumer durables rose by 11.4%
Illicit trade caused Rs 39,239 cr loss to government exchequer: Ficci (11-09-2015)
The loss to the government is inclusive of both indirect and direct taxes
Sensex holds 25,600 amid choppy trade; auto, aviation fly high (11-09-2015)
All sectoral indices, led by realty, PSU, oil & gas and banking, were in positive zone with gains of up to 1.25 per cent.
US Money Market Funds exposure to China slowing: Fitch (11-09-2015)
Most of the Chinese short-term paper in US money funds is issued from major state-controlled or affiliated banks, such as China Construction Bank, whose credit strength is based on an assumption of support from the Chinese government.
NCL Industries – Resumption of growth? (11-09-2015)
So it seems that the "mutual understanding" is still intact. Whether they can maintain this for a year or two remains to be seen.
Mutual fund AUMs to cross Rs 20 trillion mark by 2018: report (11-09-2015)
Says faster growth is backed by factors like sound macro-economic environment and favourable demographics
TRAI to float second information paper in 15 days: R.S. Sharma (11-09-2015)
The Telecom Regulatory Authority of India (TRAI) is circulating another information paper which is going to bring out the quality of service of calls specifically in the area of Delhi and Mumbai. Thereafter such surveys shall be extended to other cities, said Mr Sharma, Chairman of TRAI while inaugurating ‘11th National Summit on e-Governance & Digital India,’ organised by The Associated Chambers of Commerce and Industry of India (ASSOCHAM).
Aurobindo Pharma (11-09-2015)
Hi @drrakesh
I was Searching the orange book of Pharma and for below two months found below approvals for Aurobindo Pharma:
TELMISARTAN
CETIRIZINE HYDROCHLORIDE
ALPRAZOLAM
RALOXIFENE HYDROCHLORIDE
ENTECAVIR
IBANDRONATE SODIUM
OMEPRAZOLE
Could you please help me in below points:
How to get Estimated Market size as you have mentioned for Raloxifene Hydrochloride in your post.
Also how much competition is there.
Regards,
Kapil
Suven Lifesciences ends flat (11-09-2015)
The pharma company has announced that it had secured five product patents in China, Israel, Mexico, Singapore and Sri Lanka corresponding to its new chemical entities (NCEs) for the treatment of disorders associated with neurodegenerative diseases.